Actividad lacasa en cepas de Cryptococcus gattii aisladas de cabras

Baró, 1998, First Identification of Autochthonous Cryptococcus neoformans var. gattii Isolated from goats with predominantly severe pulmonary disease in Spain, J Clin Microbiol, 36, 458, 10.1128/JCM.36.2.458-461.1998 Casadevall, 1998 Colom, 2005, First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain, J Clin Microbiol, 43, 4538, 10.1128/JCM.43.7.3548-3550.2005 Doering, 1999, Melanin as a potential cryptococcal defence against microbicidal proteins, Med Mycol, 37, 175, 10.1080/j.1365-280X.1999.00218.x Duncan, 2005, Follow-up study of dogs and cats with asymptomatic Cryptococcus gattii infection, Med Mycol, 43, 663, 10.1080/13693780500220076 Ikeda, 2002, Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans, J Clin Microbiol, 40, 1214, 10.1128/JCM.40.4.1214-1218.2002 Kwon-Chung, 2002, Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremenomycetidae), Taxon, 51, 804, 10.2307/1555045 Kwon-Chung, 1982, Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice, J Bacteriol, 150, 1414, 10.1128/JB.150.3.1414-1421.1982 Kwon-Chung, 1986, Encapsulation and melanin production as indicators of virulence in Cryptococcus neoformans, Infect Immun, 51, 218, 10.1128/IAI.51.1.218-223.1986 Liu, 1999, Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages, Infect Immun, 67, 6034, 10.1128/IAI.67.11.6034-6039.1999 Mitchell, 1995, Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome, Clin Infect Dis, 20, 611, 10.1093/clinids/20.3.611 Mitchell, 1995, Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans, Clin Med Rev, 8, 515 Nuñez, 2000, Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and review of the literature, Chest, 118, 527, 10.1378/chest.118.2.527 Nurudeen, 1979, Regulation of melanin production by Cryptococcus neoformans, J Clin Microbiol, 10, 724, 10.1128/JCM.10.5.724-729.1979 Parks, 1993 Prabhakaran, 1969, Effect of inhibitors on phenoloxidase of Mycobacterium leprae, J Bacteriol, 100, 935, 10.1128/JB.100.2.935-938.1969 Raso, 2004, Cryptococcosis outbreak in psittacine birds in Brazil, Med Mycol, 42, 355, 10.1080/13693780410001712061 Speed, 1995, Clinical and host differences between infections with the two varieties of Cryptococcus neoformans, Clin Infect Dis, 21, 28, 10.1093/clinids/21.1.28 Torres-Rodríguez, 2006, Cryptococcosis by Cryptococcus gattii in immunocompetent goats in Spain and review of the literature, Acta Sci Vet, 34, 245, 10.22456/1679-9216.15370 Torres-Rodríguez, 2003, Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model, Med Mycol, 41, 59 Van Duin, 2002, Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin, Antimicrob Agents Chemother, 46, 3394, 10.1128/AAC.46.11.3394-3400.2002 Vidotto, 2002, Effect of different K+ concentrations on Cryptococcus neoformans phenoloxidase activity, Mycopathologia, 156, 171, 10.1023/A:1023376324422 Walton, 2005, Heitman Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans, Mol Microbiol, 57, 1381, 10.1111/j.1365-2958.2005.04779.x Waters, 2005, Cryptococcal disease and HIV infection, Expert Opin Pharmather, 6, 2633, 10.1517/14656566.6.15.2633 Williamson, 1994, Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase, J Bacteriol, 176, 656, 10.1128/jb.176.3.656-664.1994 Zhu, 2001, Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor, Infect Immun, 69, 5589, 10.1128/IAI.69.9.5589-5596.2001